Abstract

Introduction: Age is a major prognostic factor in Hodgkin's Lymphoma (HL), with impact in overall survival. Age-adapted chemotherapy regimens led to the development of distinct pediatric and adult regimens. However, the prognostic impact of adolescent age remains unknown and no specific protocols have been design to this population.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.